Predicting long-term impairments after meningioma surgery

Takeaway

Identification of determinants of long-term disease burden in people with meningioma and the development of prediction models can help early identification of patients at risk for long-term health-related quality-of-life (HRQoL) or neurocognitive impairment. This can facilitate tailored provision of information and the appropriate allocation of supportive care to those most likely to benefit.

Why this matters

Although meningioma is generally a treatable disease, many patients experience long-term impairments affecting HRQoL and neurocognitive function. Being able to predict the patients most likely to be affected by these impairments allows more efficient use of supportive care resources.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.